Tenaya Therapeutics files Form 144 for 5,053-share sale on 08/18/2025

Rhea-AI Filing Summary

Tenaya Therapeutics, Inc. (TNYA) filed a Form 144 notice for a proposed sale of 5,053 shares of its common stock through Morgan Stanley Smith Barney Operations Department, with an aggregate market value of $6,331.41. The filing lists total shares outstanding as 162,976,102 and an approximate sale date of 08/18/2025. The securities to be sold were acquired as Restricted Stock Units from the issuer on 08/18/2025, showing an acquired amount of 13,750 units and a payment date of 08/18/2025. The filer reports no sales in the past three months and includes the standard representation about nonpublic material information.

Positive

• Form 144 filed to disclose proposed sale, satisfying Rule 144 reporting requirements
• Securities originate from Restricted Stock Units, and acquisition/payment dates are stated

Negative

• Filer and issuer identifying information are not provided in the content supplied
• No context on filer relationship or trading plan dates is included, limiting governance transparency

Insights

Securities Analyst

TL;DR: Small planned sale of RSU-derived shares filed under Rule 144; minimal market impact expected based on stated quantities.

The Form 144 discloses a proposed brokered sale of 5,053 common shares with an aggregate market value of $6,331.41, originating from 13,750 restricted stock units granted and acquired on 08/18/2025. The filing confirms no reported sales in the prior three months and lists total outstanding shares as 162,976,102. This notice is procedural under Rule 144 to permit public resale and includes the required representation about material nonpublic information. There are no earnings, debt, or other financial metrics provided in this filing to assess broader company financials.

Corporate Governance Expert

TL;DR: Form 144 documents an insider or affiliate resale plan step; disclosure is routine and complies with Rule 144 formality.

The filing identifies the securities as acquired via issuer-granted restricted stock units and signals intent to sell through Morgan Stanley Smith Barney. The document contains the standard attestation that the seller is unaware of undisclosed material adverse information. No information about the filer identity, specific insider role, or any trading plan dates is provided in the content. As presented, the notice fulfills Rule 144 reporting requirements but provides limited governance context due to omitted filer and issuer identifying details in the submitted content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney Operations Department 2000 Westchester Ave Purchase NY 10577-2530	5053	6331.41	162976102	08/18/2025	Nasdaq Global Select

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Restricted Stock Unit	Issuer			13750	08/18/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Tenaya Therapeutics' (TNYA) Form 144 disclose?

The filing discloses a proposed sale of 5,053 common shares with an aggregate market value of $6,331.41, to be sold via Morgan Stanley on 08/18/2025.

Where did the shares proposed for sale come from in the Form 144?

The shares were acquired as Restricted Stock Units from the issuer on 08/18/2025, with 13,750 units shown as acquired.

Does the filing report any securities sold in the past three months?

No. The Form 144 content states "Nothing to Report" for securities sold during the past three months.

What is the approximate date of the proposed sale in the Form 144?

The approximate date of sale listed is 08/18/2025.

Which broker is named in the Form 144 for the proposed sale?

The broker named is Morgan Stanley Smith Barney Operations Department at the Purchase, NY address shown in the filing.

Does the Form 144 include a representation about material nonpublic information?

Yes. The person for whose account the securities are to be sold represents they do not know any material adverse information about the issuer that has not been publicly disclosed.